Login
$ANNX
$3.61 +$0.04 (1.12%) After hours

$ANNX SEC Filings

Filed On Filing
09 Nov 2026 10-Q
09 Nov 2026 8-K: Results of Operations and Financial Condition

Differentiated C1q Platform Advances Two Registrational Programs with Blockbuster Potential, Driving Near-Term Value Catalysts

05 Nov 2026 SCHEDULE 13G/A
25 Sep 2026 Form 4: Love Douglas, Director

Bought 26,065 shares ($99.8K)

13 Aug 2026 144
12 Aug 2026 Form 4: Blumenkranz Mark S., Director

Granted 175,000 Stock Option (Right to Buy)

12 Aug 2026 Form 3: Blumenkranz Mark S., Director

No securities owned

12 Aug 2026 10-Q
12 Aug 2026 8-K: Results of Operations and Financial Condition; Other Events

Rapid, Positive Clinical Outcomes in GBS FORWARD Study Reinforce Consistency and Reproducibility of Tanruprubart Treatment Effect Demonstrated in Phase 3 and Real-World Evidence Studies; BLA Submission Expected in Q4 2026

10 Aug 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Over Four Decades of Clinical, Scientific and Corporate Leadership Advancing Innovation in Retinal Disease

07 Aug 2026 SCHEDULE 13G
06 Aug 2026 8-K: Other Events

Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week

30 Jul 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

THIS LOAN AND SECURITY AGREEMENT (as the same may from time to time be amended, modified, supplemented or restated, this “Agreement”) dated as of July 30, 2026 (the “Effective Date”) among OXFORD FINANCE LLC, a Delaware limited liability...

27 Jul 2026 SCHEDULE 13G/A
15 Jul 2026 144
14 Jul 2026 144
08 Jul 2026 SCHEDULE 13G/A
08 Jul 2026 SCHEDULE 13G/A
15 Jun 2026 Form 4: Waddill William D., Director

Granted 65,000 Stock Option (Right to Buy)

15 Jun 2026 Form 4: Satter Muneer A, Director

Granted 65,000 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support